MTFR2 pseudogene 1 (MTFR2P1)

There is no evidence in scientific literature or biological databases that "MTFR2 pseudogene 1" (MTFR2P1) represents a functional molecule or recognized drug target. Available research and reviews focus on MTFR2 (Mitochondrial fission regulator 2), which is a functional mitochondrial regulator implicated in cancer biology, but not on any pseudogene designated MTFR2P1. Pseudogenes are generally non-functional genetic elements derived from protein-coding genes; they are not translated into active proteins nor known to serve as drug targets. The name "MTFR2P1" appears to refer to such a pseudogene, not a canonical receptor, enzyme, or similar target class[1][3]. If you intended the functional mitochondrial protein, the correct entry would be "Mitochondrial fission regulator 2 (MTFR2)". Key notes: - "MTFR2 pseudogene 1" (MTFR2P1) does not refer to a therapeutically actionable protein or receptor. - The term likely arises from genomic annotation of nonfunctional copies (pseudogenes) of the MTFR2 gene. - No biological function, disease association, or drug interaction is attributed to this pseudogene in available literature[1][3]. - For structured scientific or clinical information, only the functional MTFR2 protein—not its pseudogene—is relevant.